Agenus reported $-0.3 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Agenus USD -0.3 0.84 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
AstraZeneca USD 2.58 0.46 Mar/2026
Bristol-Myers Squibb USD 1.58 0.32 Mar/2026
Celldex Therapeutics USD -1.18 0.04 Mar/2026
CSL USD 5.07 3 Dec/2025
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Intrexon USD -0.1 0.03 Jun/2024
J&J USD 2.7 0.24 Mar/2026
Jiangsu Hengrui CNY 0.34 0.05 Mar/2026
Karyopharm Therapeutics USD -2.22 2.07 Dec/2025
MacroGenics USD -0.58 0.36 Mar/2026
Merck EUR 2.11 0.23 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Northwest Biotherapeutics USD -0.01 0.01 Sep/2025
Novartis USD 1.99 0.04 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Veracyte USD 0.52 0.01 Mar/2026